AU766801B2 - Cyclothiocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclothiocarbamate derivatives as progesterone receptor modulators Download PDF

Info

Publication number
AU766801B2
AU766801B2 AU48119/00A AU4811900A AU766801B2 AU 766801 B2 AU766801 B2 AU 766801B2 AU 48119/00 A AU48119/00 A AU 48119/00A AU 4811900 A AU4811900 A AU 4811900A AU 766801 B2 AU766801 B2 AU 766801B2
Authority
AU
Australia
Prior art keywords
substituted
alkyl
dihydro
dimethyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU48119/00A
Other languages
English (en)
Other versions
AU4811900A (en
Inventor
Mark A. Collins
James P. Edwards
Andrew Fensome
Todd K. Jones
Christopher M Tegley
Eugene A. Terefenko
Jay E. Wrobel
Puwen Zhang
Lin Zhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Ligand Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by Wyeth LLC, Ligand Pharmaceuticals Inc filed Critical Wyeth LLC
Publication of AU4811900A publication Critical patent/AU4811900A/en
Assigned to WYETH, LIGAND PHARMACEUTICALS, INC. reassignment WYETH Amend patent request/document other than specification (104) Assignors: AMERICAN HOME PRODUCTS CORPORATION, LIGAND PHARMACEUTICALS, INC.
Application granted granted Critical
Publication of AU766801B2 publication Critical patent/AU766801B2/en
Assigned to WYETH reassignment WYETH Alteration of Name(s) in Register under S187 Assignors: LIGAND PHARMACEUTICALS, INC., WYETH
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU48119/00A 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators Ceased AU766801B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US60/183013 1999-05-04
US09/552354 2000-04-19
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011749 WO2000066570A1 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (2)

Publication Number Publication Date
AU4811900A AU4811900A (en) 2000-11-17
AU766801B2 true AU766801B2 (en) 2003-10-23

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48119/00A Ceased AU766801B2 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Country Status (24)

Country Link
EP (1) EP1175411B1 (cg-RX-API-DMAC10.html)
JP (2) JP4958338B2 (cg-RX-API-DMAC10.html)
KR (1) KR100732692B1 (cg-RX-API-DMAC10.html)
CN (1) CN1131856C (cg-RX-API-DMAC10.html)
AT (1) ATE386729T1 (cg-RX-API-DMAC10.html)
AU (1) AU766801B2 (cg-RX-API-DMAC10.html)
BG (1) BG65277B1 (cg-RX-API-DMAC10.html)
BR (1) BR0010214A (cg-RX-API-DMAC10.html)
CA (1) CA2371712C (cg-RX-API-DMAC10.html)
CZ (1) CZ20013952A3 (cg-RX-API-DMAC10.html)
DE (1) DE60038108T2 (cg-RX-API-DMAC10.html)
DK (1) DK1175411T3 (cg-RX-API-DMAC10.html)
EA (1) EA004511B1 (cg-RX-API-DMAC10.html)
ES (1) ES2301482T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20043181B (cg-RX-API-DMAC10.html)
HU (1) HUP0203332A3 (cg-RX-API-DMAC10.html)
IL (1) IL146298A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011287A (cg-RX-API-DMAC10.html)
NO (1) NO321370B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515353A (cg-RX-API-DMAC10.html)
PL (1) PL351083A1 (cg-RX-API-DMAC10.html)
SG (1) SG120970A1 (cg-RX-API-DMAC10.html)
SK (1) SK15922001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103285T2 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
JP4950027B2 (ja) * 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
AR049707A1 (es) * 2004-07-07 2006-08-30 Wyeth Corp Regimenes y kits de progestina ciclica
AU2005272854B2 (en) * 2004-08-13 2012-04-26 Wyeth Tanaproget derivatives, metabolites, and uses thereof
BRPI0610438A2 (pt) 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
US7767668B2 (en) * 2005-04-28 2010-08-03 Wyeth Llc Micronized tanaproget, compositions, and methods of preparing the same
ES2431324T3 (es) * 2005-04-28 2013-11-26 Wyeth Llc Forma purificada de tanaproget
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Also Published As

Publication number Publication date
GEP20043181B (en) 2004-02-25
SK15922001A3 (sk) 2002-09-10
PL351083A1 (en) 2003-03-10
IL146298A0 (en) 2002-07-25
HUP0203332A2 (hu) 2003-01-28
JP2002543192A (ja) 2002-12-17
JP5523430B2 (ja) 2014-06-18
EA200101181A1 (ru) 2002-04-25
DK1175411T3 (da) 2008-06-09
NO20015381D0 (no) 2001-11-02
KR20020000170A (ko) 2002-01-04
NO20015381L (no) 2002-01-03
CA2371712C (en) 2009-12-22
DE60038108D1 (de) 2008-04-03
TR200103285T2 (tr) 2002-02-21
SG120970A1 (en) 2006-04-26
NO321370B1 (no) 2006-05-02
DE60038108T2 (de) 2009-02-12
JP4958338B2 (ja) 2012-06-20
EP1175411A1 (en) 2002-01-30
EA004511B1 (ru) 2004-04-29
JP2012087129A (ja) 2012-05-10
MXPA01011287A (es) 2003-07-14
ES2301482T3 (es) 2008-07-01
KR100732692B1 (ko) 2007-06-27
CZ20013952A3 (cs) 2002-05-15
BG106080A (en) 2002-05-31
AU4811900A (en) 2000-11-17
EP1175411B1 (en) 2008-02-20
BG65277B1 (bg) 2007-11-30
NZ515353A (en) 2004-03-26
CA2371712A1 (en) 2000-11-09
HUP0203332A3 (en) 2004-12-28
CN1131856C (zh) 2003-12-24
CN1349516A (zh) 2002-05-15
BR0010214A (pt) 2002-02-13
ATE386729T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
US6436929B1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
US6509334B1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
US6444668B1 (en) Combination regimens using progesterone receptor modulators
JP5523430B2 (ja) プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体
EP1173210B1 (en) Contraceptive compositions containing antiprogestinic and progestinic
AU766428B2 (en) Cyclocarbamate derivatives as progesterone receptor modulators

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: LIGAND PHARMACEUTICALS, INC., WYETH

Free format text: FORMER NAME: AMERICAN HOME PRODUCTS CORPORATION, LIGAND PHARMACEUTICALS, INC.

FGA Letters patent sealed or granted (standard patent)